Hybrid antibodies

Details for Australian Patent Application No. 2002359568 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Wu, Dayang; Rother, Russell

Agent Freehills

Pub. Number AU-B-2002359568

PCT Number PCT/US02/38450

PCT Pub. Number WO2003/048321

Priority 60/336,591 03.12.01 US

Filing date 3 December 2002

Wipo publication date 17 June 2003

Acceptance publication date 21 February 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/336,591 03.12.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002359568

21 February 2008 Application Accepted

  Published as AU-B-2002359568

19 June 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002359569-VIRTUAL DATA STORAGE (VDS) SYSTEM

2002359567-MOLECULES FOR DISEASE DETECTION AND TREATMENT